FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998331397> ?p ?o ?g. }

• W1998331397 endingPage "473" @default.
• W1998331397 startingPage "461" @default.
• W1998331397 abstract "Monoclonal antibody (MAb) CC49 reacts with tumor-associated glycoprotein (TAG)-72, a human pancarcinoma antigen. In clinical trials, radiolabeled CC49 has shown excellent tumor localization; however, many of the patients receiving MAb CC49 develop a human antimouse antibody response. In an attempt to prevent this antiimmunoglobulin response, we have developed a humanized CC49 (HuCC49) by grafting the MAb CC49 hypervariable regions onto the variable light (VL) and variable heavy (VH) frameworks of the human MAbs LEN and 21/28′ CL, respectively, while retaining those murine framework residues that may be required for the integrity of the antigen combining-site structure. The HuCC49 MAb was compared with native murine CC49 (nCC49) and chimeric CC49 (cCC49), using a variety of assays. SDS-PAGE analysis under nonreducing conditions showed that the HuCC49 MAb has virtually identical mobility to that of cCC49. Under reducing conditions, the HuCC49 yielded two bands of ~25–28 and ~50–55 kDa, characteristic of heavy and light immunoglobulin chains. In competition radioimmunoassays, HuCC49 completely inhibited the binding of 125I-labeled nCC49 to TAG-72, although 23- to 30-fold more HuCC49 was required to achieve a level of competition similar to those of cCC49 and nCC49. The relative affinity of HuCC49 was 2- to 3-fold less than those of the cCC49 and nCC49 MAbs, respectively. The plasma clearance in mice of HuCC49 was virtually identical to that of cCC49. Biodistribution studies demonstrated equivalent tumor-targeting of HuCC49 and cCC49 to human colon carcinoma xenografts. These studies thus suggest that HuCC49 and genetically modified molecules, such as sFv and domain-deleted immunoglobulins developed by using the HuCC49 variable region as a cassette, may be potentially useful in both diagnostic and therapeutic clinical trials in patients with TAG-72-positive tumors." @default.
• W1998331397 created "2016-06-24" @default.
• W1998331397 creator A5002917253 @default.
• W1998331397 creator A5021745884 @default.
• W1998331397 creator A5059931764 @default.
• W1998331397 creator A5066817014 @default.
• W1998331397 creator A5073878981 @default.
• W1998331397 creator A5080385640 @default.
• W1998331397 date "1995-10-01" @default.
• W1998331397 modified "2023-09-25" @default.
• W1998331397 title "Generation, Characterization, and<i>in Vivo</i>Studies of Humanized Anticarcinoma Antibody CC49" @default.
• W1998331397 cites W125596630 @default.
• W1998331397 cites W1775749144 @default.
• W1998331397 cites W1858317139 @default.
• W1998331397 cites W1971142781 @default.
• W1998331397 cites W1976232165 @default.
• W1998331397 cites W1981224231 @default.
• W1998331397 cites W1982679430 @default.
• W1998331397 cites W1983649348 @default.
• W1998331397 cites W1987337840 @default.
• W1998331397 cites W1989053318 @default.
• W1998331397 cites W2005178242 @default.
• W1998331397 cites W2005997381 @default.
• W1998331397 cites W2009310436 @default.
• W1998331397 cites W2009573319 @default.
• W1998331397 cites W2013580208 @default.
• W1998331397 cites W2023131765 @default.
• W1998331397 cites W2028105574 @default.
• W1998331397 cites W2031928907 @default.
• W1998331397 cites W2033692463 @default.
• W1998331397 cites W2036319555 @default.
• W1998331397 cites W2040505385 @default.
• W1998331397 cites W2046110140 @default.
• W1998331397 cites W2052150715 @default.
• W1998331397 cites W2053222732 @default.
• W1998331397 cites W2062625030 @default.
• W1998331397 cites W2064811345 @default.
• W1998331397 cites W2065335184 @default.
• W1998331397 cites W2069451410 @default.
• W1998331397 cites W2070369735 @default.
• W1998331397 cites W2074534136 @default.
• W1998331397 cites W2077170670 @default.
• W1998331397 cites W2088316376 @default.
• W1998331397 cites W2089120635 @default.
• W1998331397 cites W2100494836 @default.
• W1998331397 cites W2100837269 @default.
• W1998331397 cites W2128635872 @default.
• W1998331397 cites W2133811271 @default.
• W1998331397 cites W2165288231 @default.
• W1998331397 doi "https://doi.org/10.1089/hyb.1995.14.461" @default.
• W1998331397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8575795" @default.
• W1998331397 hasPublicationYear "1995" @default.
• W1998331397 type Work @default.
• W1998331397 sameAs 1998331397 @default.
• W1998331397 citedByCount "76" @default.
• W1998331397 countsByYear W19983313972012 @default.
• W1998331397 countsByYear W19983313972016 @default.
• W1998331397 countsByYear W19983313972017 @default.
• W1998331397 countsByYear W19983313972018 @default.
• W1998331397 countsByYear W19983313972020 @default.
• W1998331397 countsByYear W19983313972021 @default.
• W1998331397 countsByYear W19983313972022 @default.
• W1998331397 countsByYear W19983313972023 @default.
• W1998331397 crossrefType "journal-article" @default.
• W1998331397 hasAuthorship W1998331397A5002917253 @default.
• W1998331397 hasAuthorship W1998331397A5021745884 @default.
• W1998331397 hasAuthorship W1998331397A5059931764 @default.
• W1998331397 hasAuthorship W1998331397A5066817014 @default.
• W1998331397 hasAuthorship W1998331397A5073878981 @default.
• W1998331397 hasAuthorship W1998331397A5080385640 @default.
• W1998331397 hasConcept C147483822 @default.
• W1998331397 hasConcept C150903083 @default.
• W1998331397 hasConcept C153911025 @default.
• W1998331397 hasConcept C159654299 @default.
• W1998331397 hasConcept C203014093 @default.
• W1998331397 hasConcept C207001950 @default.
• W1998331397 hasConcept C2777807558 @default.
• W1998331397 hasConcept C36394416 @default.
• W1998331397 hasConcept C542903549 @default.
• W1998331397 hasConcept C86803240 @default.
• W1998331397 hasConceptScore W1998331397C147483822 @default.
• W1998331397 hasConceptScore W1998331397C150903083 @default.
• W1998331397 hasConceptScore W1998331397C153911025 @default.
• W1998331397 hasConceptScore W1998331397C159654299 @default.
• W1998331397 hasConceptScore W1998331397C203014093 @default.
• W1998331397 hasConceptScore W1998331397C207001950 @default.
• W1998331397 hasConceptScore W1998331397C2777807558 @default.
• W1998331397 hasConceptScore W1998331397C36394416 @default.
• W1998331397 hasConceptScore W1998331397C542903549 @default.
• W1998331397 hasConceptScore W1998331397C86803240 @default.
• W1998331397 hasIssue "5" @default.
• W1998331397 hasLocation W19983313971 @default.
• W1998331397 hasLocation W19983313972 @default.
• W1998331397 hasOpenAccess W1998331397 @default.
• W1998331397 hasPrimaryLocation W19983313971 @default.
• W1998331397 hasRelatedWork W1971628265 @default.
• W1998331397 hasRelatedWork W1973774944 @default.
• W1998331397 hasRelatedWork W1985628011 @default.

• next